Spain · AEMPS CIMA

GAVISCON SUSPENSION ORAL EN SOBRES SABOR MENTA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
74728
Form
SUSPENSIÓN ORAL
Composition / generic term
calcio carbonato + sodio alginato + sodio bicarbonato
Source strength
50+26,7+16 mg/ml+mg/ml+mg/ml
Authorisation holder
Reckitt Benckiser Healthcare S.A.
Marketed in source snapshot
Yes

Source-listed ingredients

  • ALGINATO SODIO — 500,00 mg
  • CALCIO CARBONATO — 160,00 mg
  • SODIO BICARBONATO — 267,00 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • GAVISCON SUSPENSION ORAL EN SOBRES SABOR MENTA, 12 sobres
  • GAVISCON SUSPENSION ORAL EN SOBRES SABOR MENTA, 2 sobres
  • GAVISCON SUSPENSION ORAL EN SOBRES SABOR MENTA, 24 sobres
  • GAVISCON SUSPENSION ORAL EN SOBRES SABOR MENTA, 30 sobres

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →